Morgan Stanley

13F Holdings History for agilon health, inc. - Common stock, par value $0.01 (AGL)

Symbol: AGL on NYSE
Investment type: Equity / Common stock, par value $0.01
Latest Disclosed Ownership: 50.2M shares
Security Ownership: 12.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Morgan Stanley ownership in agilon health, inc. Common stock, par value $0.01 (AGL)

2025-05-05 - Morgan Stanley has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 50.2M shares of agilon health, inc. Common stock, par value $0.01 (AGL). This represents 12.2% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Morgan Stanley	12.2%		$276M	50.2M			$5.50	13G/A	3/31/2025	5 May 2025 11:23:37

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	+0%	$61.2M	59.4M	+2,154,390	+3.76%	$1.03	Q3 2025
6/30/2025	0.01%	+0%	$132M	57.2M	+5,196,704	+9.99%	$2.30	Q2 2025
3/31/2025	0.02%	0%	$225M	52M	-4,204,010		$4.33	Q1 2025
12/31/2024	0.01%	+0%	$107M	56.2M	+5,296		$1.90	Q4 2024
9/30/2024	0.02%	0%	$221M	56.2M	-180,798		$3.93	Q3 2024
6/30/2024	0.03%	+0%	$369M	56.4M	+1,815,090		$6.54	Q2 2024
3/31/2024	0.03%		$8.00	1			$8.00^*	Q1 2024
3/31/2024	0.03%		$333M	54.6M			$6.10	Q1 2024
12/31/2023	0.05%		$561M	44.7M			$12.55	Q4 2023
9/30/2023	0.08%	+0.01%	$796M	44.8M	+3,674,311	+8.93%	$17.76	Q3 2023
6/30/2023	0.07%	+0.01%	$713M	41.1M	+4,527,489	+12.4%	$17.34	Q2 2023
3/31/2023	0.09%	0%	$870M	36.6M	-1,822,398	-4.74%	$23.75	Q1 2023
12/31/2022	0.07%	0%	$620M	38.4M	-2,631,010	-6.41%	$16.14	Q4 2022
9/30/2022	0.13%	-0.01%	$962M	41.1M	-2,028,734	-4.71%	$23.42	Q3 2022
6/30/2022	0.12%	0%	$941M	43.1M	-1,273,368	-2.87%	$21.83	Q2 2022
3/31/2022	0.15%	+0.01%	$1.12B	44.4M	+1,479,621	+3.45%	$25.35	Q1 2022
12/31/2021	0.14%	+0.12%	$1.16B	42.9M	+35,062,024	+448%	$27.00	Q4 2021
9/30/2021	0.03%	+0%	$205M	7.83M	+71,078	+0.92%	$26.21	Q3 2021
6/30/2021	0.04%	+0.05%	$315M	7.76M	+7,760,365	NEW	$40.57	Q2 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.